yea I agree, that's why I am expecting $4M burn this quarter for trials. Anything less, I would be surprised. If the $12M is used to complete the necessary trials, then I think that's worth the invested capital. Partners are willing to use the app and drive sales.
After trials, they will have to raise capital to scale. That capital would be to increase sales and marketing and account managers.
We are not even close to that stage yet ^ but I think late 2021/ early 2022 is a reasonable estimate of when the next cap raise could happen. By then I hope Painchek has ARR of $5M+, makes it easy to raise capital when existing cash can cover most of operating expenses.
This is a big year for homecare
PainChek General Discussion, page-17166
-
- There are more pages in this discussion • 3,247 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.002(6.67%) |
Mkt cap ! $45.80M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.8¢ | $15.39K | 528.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1693060 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 293045 | 1 |
View Market Depth
| Last trade - 15.43pm 15/07/2024 (20 minute delay) ? |
| PCK (ASX) Chart |